檢索結果 - Armstrong, A J

Novel Therapies for the Treatment of Advanced Prostate Cancer 由 Clarke, J. M., Armstrong, A. J.

獲取全文 獲取全文 獲取全文

Clinical trials for metastatic castrate-resistant prostate cancer—who is looking after the control patients? Questions for the future 由 Ardolino, L. C., Dear, R., Armstrong, A. J., Gillessen, S., Joshua, A. M.

獲取全文 獲取全文 獲取全文

Effect of Prophylactic Calcitriol Administration on Serum Ionized Calcium Concentrations after Parathyroidectomy: 78 Cases (2005–2015) 由 Armstrong, A.J., Hauptman, J.G., Stanley, B.J., Klocke, E., Burneko, M., Holt, D.E., Runge, J.J., Rubin, J.A.

獲取全文 獲取全文 獲取全文

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer 由 Armstrong, A J, Lin, P, Higano, C S, Sternberg, C N, Sonpavde, G, Tombal, B, Templeton, A J, Fizazi, K, Phung, D, Wong, E K, Krivoshik, A, Beer, T M

獲取全文 獲取全文 獲取全文

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Can... 由 Armstrong, A.J., Häggman, M., Stadler, W.M., Gingrich, J.R., Assikis, V., Polikoff, J., Damber, J.E., Belkoff, L., Nordle, Ö., Forsberg, G., Carducci, M.A., Pili, R.

獲取全文 獲取全文 獲取全文

Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways 由 Somarelli, J A, Schaeffer, D, Marengo, M S, Bepler, T, Rouse, D, Ware, K E, Hish, A J, Zhao, Y, Buckley, A F, Epstein, J I, Armstrong, A J, Virshup, D M, Garcia-Blanco, M A

獲取全文 獲取全文 獲取全文

Development and Validation of Circulating Tumor Cell Enumeration (Epic Sciences) as a Prognostic Biomarker in Men with Metastatic Castration Resistant Prostate Cancer 由 Scher, H I, Armstrong, A J, Schonhoft, J D, Gill, A, Zhao, J L, Barnett, E, Carbone, E, Lu, J, Antonarakis, E S, Luo, J, Tagawa, S, dos Anjos, C H, Yang, Q, George, D, Szmulewitz, R, Danila, D C, Wenstrup, R, Gonen, M, Halabi, S

獲取全文 獲取全文 獲取全文

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy 由 Beer, T.M., Armstrong, A.J., Rathkopf, D.E., Loriot, Y., Sternberg, C.N., Higano, C.S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., Davis, I.D., de Bono, J.S., Evans, C.P., Fizazi, K., Joshua, A.M., Kim, C.-S., Kimura, G., Mainwaring, P., Mansbach, H., Miller, K., Noonberg, S.B., Perabo, F., Phung, D., Saad, F., Scher, H.I., Taplin, M.-E., Venner, P.M., Tombal, B.

獲取全文 獲取全文 獲取全文

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet 由 Armstrong, A J, Antonarakis, E S, Taplin, M -E, Kelly, W K, Beltran, H, Fizazi, K, Dahut, W L, Shore, N, Slovin, S, George, D, Carducci, M A, Corn, P, Danila, D, Dreicer, R, Heath, E, Rathkopf, D, Liu, G, Nanus, D, Stein, M, Smith, M R, Sternberg, C, Wilding, G, Nelson, P S, Halabi, S, Kantoff, P, Clarke, N W, Evans, C P, Heidenreich, A, Mottet, N, Gleave, M, Morris, M J, Scher, H I

獲取全文 獲取全文 獲取全文